Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt | ($135.5M) | ($132.2M) | ($89.5M) | $18.3M | $77.6M | $17.2M | ($23.6M) | $62.5M | ($9,485.0K) | $149.3M | $576.5M | $827.5M | $812.3M | $789.1M | $876.5M | $980.1M | $619.3M | $886.6M | $1,357.5M | $613.4M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, IDEXX Laboratories, Inc.'s last 12-month Net Debt is ($120.5M), based on the financial report for Dec 31, 2024 (Q4 2024).
Over the last year, IDEXX Laboratories, Inc.'s Net Debt growth was N/A. The average annual Net Debt growth rates for IDEXX Laboratories, Inc. have been N/A over the past three years, N/A over the past five years.